Modalità Di Creazione Di CBG
La CBG deriva da giovani piante di cannabis, che contengono quantità di CBG superiori a quelle di piante completamente sviluppate. Alcuni ceppi di cannabis, come White CBG, Super Glue CBG e Jack Frost CBG, hanno anche un tenore di CBG maggiore rispetto ad altri ceppi. Questi ceppi sono coltivati specificamente per produrre maggiori quantità di CBG. Sia il CBD che il THC iniziano come CBGA, una forma acida di CBG. Per questo motivo le piante di cannabis più giovani contengono concentrazioni superiori di CBG. Negli impianti completamente sviluppati con concentrazioni elevate di THC e CBD, si riscontreranno concentrazioni molto basse di CBG. Ciò si verifica perché la maggior parte dei CBG è già stata convertita in CBD e THC man mano che l’impianto si è sviluppato. A causa della difficoltà di ottenere CBG, i coltivatori di cannabis hanno sperimentato con l’incrocio e la manipolazione genetica per aiutare le piante di cannabis a produrre più CBG.
Funzionamento di CBG
CBG è trattata dal sistema endocannabinoide dell’organismo. Il sistema endocannabinoide è costituito da molecole e recettori nei nostri corpi che sono responsabili di mantenere i nostri corpi in uno stato ottimale, indipendentemente da quello che accade nel nostro ambiente esterno. Nei nostri corpi, il CBG imita endocannabinoidi, i composti naturali che il nostro corpo produce.
Recipienti di cannabinoidi del corpo
Il nostro corpo contiene due tipi di recettori cannabinoidi: CB1 e CB2. I recettori CB1 si trovano nel sistema nervoso e nel cervello, mentre i recettori CB2 si trovano nel sistema immunitario e in altre aree del corpo. La CBG lavora con entrambi i recettori dove si ritiene che rafforzi la funzione di anandamide, un neurotrasmettitore che contribuisce a migliorare il piacere e la motivazione, a regolare l’appetito e il sonno, e ad alleviare il dolore. A differenza del THC, CBG non ha effetti psicotropi, quindi non è un effetto elevato.
Potenziali benefici di CBG
Come la CBD, la CBG è stata usata per combattere il dolore senza l’effetto inebriante dei cannabinoidi come la THC. La ricerca dimostra che anche CBG può avere effetti terapeutici. Tuttavia, gli studi sull’uomo sono sparsi e sono necessarie ulteriori ricerche. Alcuni promettenti studi sugli animali mostrano che CBG potrebbe aiutare a curare alcune condizioni mediche.
Lately we’ve been hearing more and more about cannabinoids, especially THC and CBD. But you’ve probably never heard of cannabichromene, also known as CBC. Discovered over 50 years ago, CBC is considered one of the six outstanding cannabinoids in medical research. It doesn’t get the same attention as other cannabinoids, but the benefits of the cannabinoid CBC are extremely promising.
CBC has the same origins as THC and CBD, all of which are derived from cannabigerolic acid (CBGA). Cannabis plants produce CBGA, the precursor to three main cannabinoids: tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), and cannabichromene carboxylic acid (CBCA).
For CBC, it converts from CBGA to cannabichromene carboxylic acid (CBCA), and then finally to CBC after exposure to heat or ultraviolet light.
What is CBC?
Cannabichromene belongs to the family of organic compounds known as cannabinoids. Contained in hemp and different varieties of marijuana, CBC is synthesized after CBCA is exposed to heat and light. However, it is different from most cannabinoids because it has a low affinity for our CB receptors. Instead, CBC binds to TRPV receptors involved in the perceptions of temperature changes and other stimuli at the cellular level. Although CBC can bring benefits individually, most studies have examined the effects of CBC along with other cannabinoids such as CBD and THC. Cannabichromene shows excellent synergy with other cannabinoids, but despite being an important compound within the biological structure of Cannabis sativa, it is only produced in small amounts.
CBC does not cause intoxication, it does not produce euphoria, like THC. The reason it is not intoxicating is that it binds poorly to CB1 cannabinoid receptors in the brain. But CBC does bind to other receptors in the body, such as vanilloid receptor 1 (TRPV1) and transient potential ankyrin receptor 1 (TRPA1), both of which are linked to pain perception. When CBC activates these receptors, elevated levels of the body’s natural endocannabinoids, such as anandamide, are released.
CBC has separate benefits, but researchers also believe it works in synergy with other cannabinoids, a term known as the entourage effect. This effect of THC working together with CBD is well known, but it is not known whether other cannabinoids also have an entourage effect.
Cannabichromene has been shown to block the pain and inflammation associated with osteoarthritis. Cannabinoids such as CBC act on inflammation differently than nonsteroidal anti-inflammatory drugs (NSAIDs) and do not have the side effects of these drugs. In another example of an entourage effect, CBC in combination with THC had a significant anti-inflammatory response in an animal study: together, the two cannabinoids produced a much greater effect on inflammation than separately.
The benefits that CBC would have have far-reaching implications. Below are some medical conditions that can be alleviated by cannabichromene.
Cannabichromene may be a powerful cancer fighter, and the reason might be its interaction with the body’s natural endocannabinoid, anandamide. CBC also appears to inhibit the uptake of anandamide, allowing it to remain longer in the bloodstream.
A recent study in which tumor growth was initiated in mice (two-stage mouse skin carcinogenesis model) showed cannabinoids might be effective in inhibiting both inflammation and tumor growth. Since anandamide has been shown to fight breast cancer in vitro and in vivo, this shows promise that CBC and other cannabinoids might one day be a chemopreventive agent.
CBC as a potential cancer fighter was first published in a 2006 study that looked at cannabinoids other than THC and their possible effects on cancer. While THC is known for its anti-tumor properties for several different forms of cancer, its powerful psychotropic qualities can make it difficult for chemotherapy use. So far, research has found CBC to be the second-most-potent cannabinoid at inhibiting the growth of new cancer cells (CBG was the most potent).
Pain and Inflammation
Cannabichromene has been shown to block pain and inflammation associated with collagen-induced osteoarthritis. Cannabinoids like CBC act on inflammation differently than non-steroidal anti-inflammatory drugs (NSAIDs) do, and don’t have the side effects of these medications. In another example of the entourage effect, CBC in combination with THC had significant anti-inflammatory response in a recent animal study; together, the two cannabinoids produced a much greater effect on inflammation than by themselves.
In a 2013 mouse study, CBC had a positive effect on neural stem progenitor cells (NSPCs), a cell essential to healthy brain function. NSPCs became more viable when in the presence of CBC, and that shows promise because NSPCs differentiate into astroglial cells, the most important cells for maintaining brain homeostasis. The astroglial cells perform a whole host of functions, including neurotransmitter direction and defending against oxidative stress. Astroglia counteract many of these issues—oxidative stress, inflammation, toxicity—that create neurological diseases and brain pathologies like Alzheimer’s disease.
A research team that had previously shown CBD’s effect on acne studied other cannabinoids, including CBC, for the same effects. Indeed, CBC was shown to be a powerful inhibitor of acne. As a skin disease, acne is characterized by excess sebum production and sebaceous gland inflammation. It turns out that CBC exhibited powerful anti-inflammatory properties and also suppressed excessive lipid production in the sebaceous glands. CBC also reduced levels of arachidonic acid (AA), which is needed to create the lipogenesis. More research is needed, but CBC might just one day become a very powerful antiacne treatment.